ArticleFrontiers in cardiovascular medicine2025
Machine learning-based prediction model for recurrence after radiofrequency catheter ablation in patients with atrial fibrillation.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predictive accuracy of left atrial strain parameters for risk of atrial fibrillation recurrence: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- Three-Dimensional Left Atrial Geometry in Atrial Fibrillation: Imaging Biomarkers, Substrate Phenotyping, and Ablation Outcome Prediction.Diagnostics (Basel, Switzerland) · 2026Review
- Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- Diabetic Atrial Cardiomyopathy: Pathogenesis, Diagnosis, Management, AI-Driven Diagnosis, and Risk Prediction.Journal of diabetes research · 2026Review
- Novel predictors of late recurrence after catheter ablation for atrial fibrillation: from biomarkers to artificial intelligence models.Frontiers in cardiovascular medicine · 2026Review
- Atrial fibrillation type-specific prediction of recurrence after catheter ablation: the pivotal role of right atrial remodeling revealed by explainable machine learning.Frontiers in cardiovascular medicine · 2026Article
- Artificial Intelligence in Cardiac Electrophysiology: A Clinically Oriented Review with Engineering Primers.Bioengineering (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study seeks to develop and validate a machine learning (ML) model for predicting atrial fibrillation (AF) recurrence at 12 months following radiofrequency catheter ablation (RFCA). Methods: A total of 430 consecutive patients with atrial fibrillation undergoing first-time radiofrequency catheter ablation were retrospectively enrolled between June 2022 and December 2023. Patients were randomly assigned to either a training cohort (70%) or a testing cohort (30%). Four ML algorithms were employed to develop prediction models. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and accuracy. The SHapley Additive exPlanations (SHAP) methodology was employed to interpret the best-performing model and quantify each feature's contribution to its predictions. Results: Among the four machine learning algorithms evaluated, the Light Gradient Boosting Machine (LightGBM) model showed promising predictive performance on the testing set, achieving an accuracy of 0.721 and an AUC of 0.848 (95% CI: 0.778-0.919). Interpretation of the LightGBM model using SHAP analysis identified B-type natriuretic peptide (BNP) and the neutrophil-to-lymphocyte ratio (NLR) as the most impactful predictors for AF recurrence. The analysis revealed that higher levels of BNP and NLR were strongly associated with an increased risk of recurrence, whereas higher levels of albumin and lymphocyte count were protective. Other significant predictors included left atrial diameter (LAD) and nonparoxysmal atrial fibrillation (NPAF). Conclusion: Machine learning-based models show modest but promising performance for assessing AF recurrence risk after RFCA using routine clinical data. While requiring extensive external validation before clinical application, these models highlight the potential of ML to inform future risk stratification and guide personalized follow-up strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.